376 related articles for article (PubMed ID: 29802174)
1. Effect of Huaier granule on recurrence after curative resection of HCC: a multicentre, randomised clinical trial.
Chen Q; Shu C; Laurence AD; Chen Y; Peng BG; Zhen ZJ; Cai JQ; Ding YT; Li LQ; Zhang YB; Zheng QC; Xu GL; Li B; Zhou WP; Cai SW; Wang XY; Wen H; Peng XY; Zhang XW; Dai CL; Bie P; Xing BC; Fu ZR; Liu LX; Mu Y; Zhang L; Zhang QS; Jiang B; Qian HX; Wang YJ; Liu JF; Qin XH; Li Q; Yin P; Zhang ZW; Chen XP
Gut; 2018 Nov; 67(11):2006-2016. PubMed ID: 29802174
[TBL] [Abstract][Full Text] [Related]
2. Huaier granule prevents the recurrence of early-stage hepatocellular carcinoma after thermal ablation: A cohort study.
Wang Z; Yu XL; Zhang J; Cheng ZG; Han ZY; Liu FY; Dou JP; Kong Y; Dong XJ; Zhao QX; Yu J; Liang P; Tang WZ
J Ethnopharmacol; 2021 Dec; 281():114539. PubMed ID: 34428522
[TBL] [Abstract][Full Text] [Related]
3. Hepatocellular Carcinoma Patients May Benefit From Postoperative Huaier Aqueous Extract After Liver Transplantation.
Lei JY; Yan LN; Zhu JQ; Wang WT
Transplant Proc; 2015 Dec; 47(10):2920-4. PubMed ID: 26707314
[TBL] [Abstract][Full Text] [Related]
4. Long-term results of a randomized, observation-controlled, phase III trial of adjuvant interferon Alfa-2b in hepatocellular carcinoma after curative resection.
Chen LT; Chen MF; Li LA; Lee PH; Jeng LB; Lin DY; Wu CC; Mok KT; Chen CL; Lee WC; Chau GY; Chen YS; Lui WY; Hsiao CF; Whang-Peng J; Chen PJ;
Ann Surg; 2012 Jan; 255(1):8-17. PubMed ID: 22104564
[TBL] [Abstract][Full Text] [Related]
5. Adjuvant sorafenib for hepatocellular carcinoma after resection or ablation (STORM): a phase 3, randomised, double-blind, placebo-controlled trial.
Bruix J; Takayama T; Mazzaferro V; Chau GY; Yang J; Kudo M; Cai J; Poon RT; Han KH; Tak WY; Lee HC; Song T; Roayaie S; Bolondi L; Lee KS; Makuuchi M; Souza F; Berre MA; Meinhardt G; Llovet JM;
Lancet Oncol; 2015 Oct; 16(13):1344-54. PubMed ID: 26361969
[TBL] [Abstract][Full Text] [Related]
6. Huaier granule prolongs overall survival after curative resection of hepatocarcinoma carcinoma: A propensity score analysis.
Luo S; Hu H
J Ethnopharmacol; 2023 Jan; 301():115774. PubMed ID: 36206867
[TBL] [Abstract][Full Text] [Related]
7. Molecular predictors of prevention of recurrence in HCC with sorafenib as adjuvant treatment and prognostic factors in the phase 3 STORM trial.
Pinyol R; Montal R; Bassaganyas L; Sia D; Takayama T; Chau GY; Mazzaferro V; Roayaie S; Lee HC; Kokudo N; Zhang Z; Torrecilla S; Moeini A; Rodriguez-Carunchio L; Gane E; Verslype C; Croitoru AE; Cillo U; de la Mata M; Lupo L; Strasser S; Park JW; Camps J; Solé M; Thung SN; Villanueva A; Pena C; Meinhardt G; Bruix J; Llovet JM
Gut; 2019 Jun; 68(6):1065-1075. PubMed ID: 30108162
[TBL] [Abstract][Full Text] [Related]
8. Administration of adjuvant oral tegafur/uracil chemotherapy post hepatocellular carcinoma resection: A randomized controlled trial.
Ishizuka M; Kubota K; Nemoto T; Shimoda M; Kato M; Iso Y; Tago K
Asian J Surg; 2016 Jul; 39(3):149-54. PubMed ID: 26123137
[TBL] [Abstract][Full Text] [Related]
9. Adjuvant therapy with capecitabine postpones recurrence of hepatocellular carcinoma after curative resection: a randomized controlled trial.
Xia Y; Qiu Y; Li J; Shi L; Wang K; Xi T; Shen F; Yan Z; Wu M
Ann Surg Oncol; 2010 Dec; 17(12):3137-44. PubMed ID: 20602260
[TBL] [Abstract][Full Text] [Related]
10. Perioperative blood transfusion does not influence recurrence-free and overall survivals after curative resection for hepatocellular carcinoma: A Propensity Score Matching Analysis.
Yang T; Lu JH; Lau WY; Zhang TY; Zhang H; Shen YN; Alshebeeb K; Wu MC; Schwartz M; Shen F
J Hepatol; 2016 Mar; 64(3):583-93. PubMed ID: 26596543
[TBL] [Abstract][Full Text] [Related]
11. Adjuvant sorafenib after heptectomy for Barcelona Clinic Liver Cancer-stage C hepatocellular carcinoma patients.
Xia F; Wu LL; Lau WY; Huan HB; Wen XD; Ma KS; Li XW; Bie P
World J Gastroenterol; 2016 Jun; 22(23):5384-92. PubMed ID: 27340354
[TBL] [Abstract][Full Text] [Related]
12. Tumor-stroma ratio is a prognostic factor for survival in hepatocellular carcinoma patients after liver resection or transplantation.
Lv Z; Cai X; Weng X; Xiao H; Du C; Cheng J; Zhou L; Xie H; Sun K; Wu J; Zheng S
Surgery; 2015 Jul; 158(1):142-50. PubMed ID: 25890776
[TBL] [Abstract][Full Text] [Related]
13. Adjuvant treatment strategy after curative resection for hepatocellular carcinoma.
Zhang W; Zhang B; Chen XP
Front Med; 2021 Apr; 15(2):155-169. PubMed ID: 33754281
[TBL] [Abstract][Full Text] [Related]
14. Treatment for extrahepatic metastasis of hepatocellular carcinoma following successful hepatic resection.
Aramaki M; Kawano K; Kai T; Yokoyama H; Morii Y; Sasaki A; Yoshida T; Kitano S
Hepatogastroenterology; 1999; 46(29):2931-4. PubMed ID: 10576375
[TBL] [Abstract][Full Text] [Related]
15. Thymalfasin, a promising adjuvant therapy in small hepatocellular carcinoma after liver resection.
He C; Peng W; Li C; Wen TF
Medicine (Baltimore); 2017 Apr; 96(16):e6606. PubMed ID: 28422855
[TBL] [Abstract][Full Text] [Related]
16. Postoperative Adjuvant Transcatheter Arterial Chemoembolization After R0 Hepatectomy Improves Outcomes of Patients Who have Hepatocellular Carcinoma with Microvascular Invasion.
Sun JJ; Wang K; Zhang CZ; Guo WX; Shi J; Cong WM; Wu MC; Lau WY; Cheng SQ
Ann Surg Oncol; 2016 Apr; 23(4):1344-51. PubMed ID: 26714945
[TBL] [Abstract][Full Text] [Related]
17. Hepatocellular carcinoma cases with high levels of c-Raf-1 expression may benefit from postoperative adjuvant sorafenib after hepatic resection even with high risk of recurrence.
Lei J; Zhong J; Hao J; Liu Z; Zhang P; Wu L; Yan L; Zhu J; Zeng Y; Li B; Wen T; Wang W
Oncotarget; 2016 Jul; 7(27):42598-42607. PubMed ID: 26981887
[TBL] [Abstract][Full Text] [Related]
18. Uracil-tegafur as an adjuvant for hepatocellular carcinoma: a randomized trial.
Hasegawa K; Takayama T; Ijichi M; Matsuyama Y; Imamura H; Sano K; Sugawara Y; Kokudo N; Makuuchi M
Hepatology; 2006 Oct; 44(4):891-5. PubMed ID: 17006925
[TBL] [Abstract][Full Text] [Related]
19. Adjuvant
Li J; Xing J; Yang Y; Liu J; Wang W; Xia Y; Yan Z; Wang K; Wu D; Wu L; Wan X; Yang T; Gao C; Si A; Wang H; Wu M; Lau WY; Chen Z; Shen F
Lancet Gastroenterol Hepatol; 2020 Jun; 5(6):548-560. PubMed ID: 32164877
[TBL] [Abstract][Full Text] [Related]
20. Adjuvant sorafenib therapy in patients with resected hepatocellular carcinoma: evaluation of predictive factors.
Zhang W; Zhao G; Wei K; Zhang Q; Ma W; Wu Q; Zhang T; Kong D; Li Q; Song T
Med Oncol; 2015 Apr; 32(4):107. PubMed ID: 25750040
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
